Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?

C. B. Confavreux, R. Casey, A. Varennes, J. Goudable, R. D. Chapurlat, P. Szulc

Open source

DOI
10.1007/s00198-016-3540-8
Published
2016-03-23
Container
Osteoporosis International
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00198-016-3540-8,
  title = {Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?},
  author = {C. B. Confavreux and R. Casey and A. Varennes and J. Goudable and R. D. Chapurlat and P. Szulc},
  year = {2016},
  journal = {Osteoporosis International},
  doi = {10.1007/s00198-016-3540-8},
  url = {https://doi.org/10.1007/s00198-016-3540-8}
}

RIS

TY  - JOUR
TI  - Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?
AU  - C. B. Confavreux
AU  - R. Casey
AU  - A. Varennes
AU  - J. Goudable
AU  - R. D. Chapurlat
AU  - P. Szulc
PY  - 2016
JO  - Osteoporosis International
DO  - 10.1007/s00198-016-3540-8
UR  - https://doi.org/10.1007/s00198-016-3540-8
ER  - 

APA

Confavreux, C. B., Casey, R., Varennes, A., Goudable, J., Chapurlat, R. D., & Szulc, P. (2016). Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?. Osteoporosis International. https://doi.org/10.1007/s00198-016-3540-8

Source records